BioNTech forms cancer immunotherapies partnership with UK Government
Collaboration will focus on providing up to 10,000 patients with personalised mRNA by 2030
Read More
Tag: immunotherapy
Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation
Treatment involves adults with certain forms of advanced stomach and oesophageal cancer
Read More
Study brings personalised immunotherapy prescriptions closer
Research showed that prescribing based solely on levels of proteins present is unlikely to be suitable
Read More
Stallergenes Greer and Aptar Pharma to develop immunotherapy treatment device
The development of the device is being carried out by Aptar Pharma’s Digital Health group
Read More
Sanofi, Regeneron’s Libtayo cleared for basal cell carcinoma
Libtayo is the first immunotherapy indicated for patients with advanced basal cell carcinoma
Read More
PARP inhibitors could exploit weaknesses in a range of cancers
Drug type could offer a new approach to treating a number of cancers with PBRM1 mutations
Read More
FDA approves GSK’s Jemperli for dMMR endometrial cancer
PD-1 inhibitor approved to treat patients with specific biomarker
Read More
Early promise for new immunotherapy combo in brain cancer
Experimental drug plus immunotherapy demonstrated early potential in aggressive brain cancer
Read More
Radiotherapy responses may be improved with targeted immunotherapy, study suggests
Researchers studied inflammation in bowel tumour samples taken before and after radiotherapy
Read More
AZ’s Imfinzi fails to improve overall survival in head and neck cancer again
Immunotherapy has previously failed in this therapy area
Read More
Boehringer Ingelheim and Enara Bio join forces to discover cancer immunotherapies
Agreement will leverage Enara’s novel Dark Antigen discovery platform
Read More
NICE no for BMS’ Opdivo for head and neck cancer
Opdivo is currently available on the Cancer Drugs Fund
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
